Cleveland question desk · plain words · source trail included
No mystery language. Each answer starts with what matters most, then adds the limit.
As of September 2026, some peptide medicines are FDA-approved. But “peptide therapy” is not a kind of treatment the law recognises, and it is not a stamp of approval that covers every peptide.
See the product lanesAs of September 2026, a compounded medicine lacks FDA approval however carefully a good pharmacy prepares it.
Read the compounding noteAs of September 2026, Ohio allows a first online visit either live or by sending in your health details for the clinician to read later (called “store-and-forward”), as long as it is as thorough as a proper first visit.
See the care pathIf appropriate care needs a physical exam or diagnostic test, professional guidance calls for arranging it or referring the patient for in-person care.
Compare visit settingsAs of September 2026, a pharmacy based in another state must hold Ohio licensing before it mails prescription medicine here.
Open the Ohio sourcesAs of September 2026, being registered with the FDA, or having a drug on the FDA’s product list, does not mean the FDA approved it.
A “drug listing” is just an entry a company files to tell the FDA what it makes.
See which record proves whatAnyone quoting a single figure is guessing. The next notes separate visit fees, memberships, medicine, testing and insurance.
As of September 2026, one brand-name weight medicine could have five different prices, depending on who pays and how.
The cost notes explain each one, and the insurance notes cover Medicare.
The cost notes show which number is which and what may be missing.